Fuller & Thaler Asset Management, Inc. Supernus Pharmaceuticals, Inc. Transaction History

Fuller & Thaler Asset Management, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$28.51 - $32.9 $3,164 - $3,651	-111 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$26.37 - $34.22 $4,799 - $6,228	-182 Reduced 62.12%	111 $3,000
Q3 2021 Nov 10, 2021	SELL	$23.54 - $31.39 $12.3 Million - $16.4 Million	-521,967 Reduced 99.94%	293 $8,000
Q2 2021 Aug 13, 2021	BUY	$26.72 - $33.19 $5.44 Million - $6.76 Million	203,554 Added 63.87%	522,260 $16.1 Million
Q1 2021 May 13, 2021	SELL	$24.15 - $31.45 $23.7 Million - $30.9 Million	-983,309 Reduced 75.52%	318,706 $8.34 Million
Q4 2020 Feb 11, 2021	BUY	$17.7 - $25.81 $5.64 Million - $8.22 Million	318,620 Added 32.4%	1,302,015 $32.8 Million
Q3 2020 Nov 09, 2020	BUY	$20.2 - $25.05 $534,714 - $663,098	26,471 Added 2.77%	983,395 $20.5 Million
Q2 2020 Aug 13, 2020	BUY	$17.09 - $24.89 $7.79 Million - $11.3 Million	455,532 Added 90.85%	956,924 $22.7 Million
Q1 2020 May 06, 2020	SELL	$14.45 - $24.69 $258,351 - $441,432	-17,879 Reduced 3.44%	501,392 $9.02 Million
Q4 2019 Feb 14, 2020	SELL	$19.93 - $29.13 $6.24 Million - $9.12 Million	-312,976 Reduced 37.61%	519,271 $12.3 Million
Q3 2019 Nov 13, 2019	BUY	$25.47 - $33.37 $17.1 Million - $22.4 Million	671,190 Added 416.74%	832,247 $22.9 Million
Q2 2019 Aug 13, 2019	BUY	$29.96 - $38.87 $4.83 Million - $6.26 Million	161,057 New	161,057 $5.33 Million

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.